Perioperative Tislelizumab Plus Chemotherapy Versus Chemotherapy Alone in MHC-II-Positive Gastric/GEJ Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Perioperative Tislelizumab Plus Chemotherapy Versus Chemotherapy Alone in MHC-II-Positive Gastric/GEJ Cancer	Gastric Cancer Stage	Not yet recruiting	Phase 3	2025-07-16		NCT07068516

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Liaoning Cancer Hospital & Institute	53
Sichuan Cancer Hospital and Research Institute	64
Xiangdong Cheng	5

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital)	Hangzhou	China	4

Clinical trials